Endomag Revenue and Competitors

Cambridge,

Location

$39.8M

Total Funding

Estimated Revenue & Valuation

  • Endomag's estimated annual revenue is currently $51.8M per year.(i)
  • Endomag's estimated revenue per employee is $313,750
  • Endomag's total funding is $39.8M.

Employee Data

  • Endomag has 165 Employees.(i)
  • Endomag grew their employee count by 35% last year.

Endomag's People

NameTitleEmail/Phone
1
CTOReveal Email/Phone
2
COOReveal Email/Phone
3
CMOReveal Email/Phone
4
CEOReveal Email/Phone
5
Regulatory OfficerReveal Email/Phone
6
QA/RA OfficerReveal Email/Phone
7
QA/RA OfficerReveal Email/Phone
8
General CounselReveal Email/Phone
9
Customer Care DirectorReveal Email/Phone
10
Chief People OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.7M48-33%N/AN/A
#2
$6.8M52-9%N/AN/A
Add Company

What Is Endomag?

Endomag is a medical technology company devoted to improving the global standard of cancer care. Our Sentimag® probe, Magseed® marker and Magtrace® lymphatic mapping agent are already in use by many of the world's leading physicians and cancer centres. Our goal is to help women with breast cancer avoid surgery when it isn't needed, and experience better outcomes when it is. We've helped tens of thousands of women around the world access more precise and less invasive breast cancer care. Founded in 2007 as a spin-out from the University of Houston and the University College London (UCL), we continue to develop our unique clinical platform from our headquarters in Cambridge, United Kingdom.

keywords:N/A

$39.8M

Total Funding

165

Number of Employees

$51.8M

Revenue (est)

35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Endomag News

2022-04-17 - Breast Lesion Localization Methods Market Size, Scope And ...

... Players – C.R. BARD, Cook Medical, Cianna Medical, Eckert & Ziegler, Theragenics, Argon Medical Devices, SOMATEX Medical, IsoAid, Endomag, Ranfac.

2020-12-01 - Endomag secures £15 million ($20 million) in Series D funding

Endomag secures £15 million ($20 million) in Series D funding 01-12-2020 Endomag, a breast cancer market leader and one of the UK’s fastest growing private technology businesses1, has secured £15m (~$20m) in Series D funding. These funds are earmarked for expanding access to new advanced techn ...

2020-12-01 - Endomag secures £15 million ($20 million) in Series D funding

Endomag secures £15 million ($20 million) in Series D funding 01-12-2020 Endomag, a breast cancer market leader and one of the UK’s fastest growing private technology businesses1, has secured £15m (~$20m) in Series D funding. These funds are earmarked for expanding access to new advanced techn ...

2020-12-01 - Improving breast cancer care: UK-based medtech startup Endomag secures €16.73M in series D funding

Almost every sector has been enriched with the use of modern technology, and healthcare is no different. There are numerous medtech or health tech startups that have come up with innovative new solutions to health problems. The UK-based startup Endomag is no different. The startup offers multipl ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$26.3M1656%N/A
#2
$29.2M166N/AN/A
#3
$46.1M167-5%N/A
#4
$26.6M167N/AN/A
#5
$15M1677%N/A